Calcium Zinc Gluconate Oral Solution
Approval number: National Drug Standard H20193310
Specification: 10 ml: Calcium gluconate 0.6 g, Zinc gluconate 0.03 g, L-lysine hydrochloride 0.1 g
Indications: Used to treat diseases caused by calcium and zinc deficiency, including osteoporosis, tetany, osteogenesis imperfecta, rickets, calcium supplementation for pregnant and lactating women, calcium for menopausal women, delayed growth and development in children, lack of appetite, anorexia, recurrent oral ulcers, and acne.
Key words:
Calcium Zinc Gluconate Oral Solution
Classification:
Product Description
MORE PRODUCTS
Related Products
Welcome your message consultation

.

Concerned about the public.
Qingdao Double Whale Pharmaceutical
Telephone:+86-532-87718629
Address: No.2 Double Whale Road, Liuting Industrial Park, Chengyang District, Qingdao
E-mail:doublewhale@qddwp.com
Adverse event report/product quality consultation telephone
400-006-2560
All rights reserved©2024 Qingdao Double Whale Pharmaceutical Co., Ltd